Unlocking the mRNA technology for life-saving therapeutics
Abogen Biosciences is China's leading fully integrated mRNA medicines company, with proprietary platforms spanning mRNA sequence design, lipid nanoparticle (LNP) delivery, and scalable GMP manufacturing. Its Dynamic Precision Mixing (DPM) technology and ionizable lipid library have been validated in global Phase III trials enrolling 30,000+ participants. The company's pipeline spans immuno-oncology, autoimmune diseases, and infectious disease vaccines, with AI integrated across every development stage.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2021
Aug 2021
Apr 2021
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
